Johnson & Johnson’s Latest 3Q Reflects Talc Charge, Firefly Acquisition and Sail Collaboration

Johnson & Johnson says its latest third-quarter results reflect a one-time special charge for a proposed talc litigation resolution, the acquisition of Firefly Bio and a strategic collaboration with Sail Biomedicines.